Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
USBC
7601
USBC Inc
USBC
$198M
| $309 | ﹤0.01% |
986
| – | – |
2022 Q3
15 quarters
|
|
|
SPCH
7602
Leverage Shares 2X Long SPCX Daily ETF
SPCH
$432M
| $306 | ﹤0.01% |
+20
| New | +$320 |
2026 Q2
0 quarters
|
|
|
EPSM
7603
Epsium Enterprise
EPSM
$15.3M
| $304 | ﹤0.01% |
251
| – | – |
2025 Q3
3 quarters
|
|
|
BLRK
7604
Bluerock Acquisition Corp
BLRK
$233M
| $299 | ﹤0.01% |
30
+22
| +275% | +$219 |
2026 Q1
1 quarter
|
|
|
DMAA
7605
Drugs Made In America Acquisition Corp
DMAA
$263M
| $298 | ﹤0.01% |
28
-30
| -52% | -$318 |
2025 Q1
5 quarters
|
|
|
HLXC
7606
Helix Acquisition Corp III
HLXC
$232M
| $298 | ﹤0.01% |
28
+22
| +367% | +$226 |
2026 Q1
1 quarter
|
|
7607
Cardlytics
CDLX
$12.1M
| $297 | ﹤0.01% |
66
+3
| +5% | +$22 |
2018 Q1
33 quarters
|
|
7608
Exicure
XCUR
$6.87M
| $297 | ﹤0.01% |
143
-15
| -9% | -$48 |
2019 Q3
27 quarters
|
|
|
AIXI
7609
Xiao-I
AIXI
$1.15M
| $296 | ﹤0.01% |
23
| – | – |
2024 Q4
6 quarters
|
|
|
IBX
7610
Tradr 2X Long IBM Daily ETF
IBX
$41.7M
| $295 | ﹤0.01% |
+10
| New | +$250 |
2026 Q2
0 quarters
|
|
|
ENHA
7611
Enhanced Group Inc
ENHA
$171M
| $287 | ﹤0.01% |
100
+26
| +35% | +$174 |
2025 Q4
2 quarters
|
|
|
APAC
7612
StoneBridge Acquisition II Corp
APAC
| $285 | ﹤0.01% |
28
-5
| -15% | -$51 |
2025 Q4
2 quarters
|
|
7613
Residential REIT ETF
HAUS
$7.25M
| $283 | ﹤0.01% |
+15
| New | +$278 |
2026 Q2
0 quarters
|
|
7614
SMX (Security Matters) Plc
SMX
$4.13M
| $281 | ﹤0.01% |
21
+17
| +425% | +$1.63K |
2025 Q4
2 quarters
|
|
|
SDHI
7615
Siddhi Acquisition Corp
SDHI
$368M
| $281 | ﹤0.01% |
27
+9
| +50% | +$94 |
2026 Q1
1 quarter
|
|
7616
Upland Software
UPLD
$10.6M
| $280 | ﹤0.01% |
60
+1
| +2% | +$7 |
2014 Q4
46 quarters
|
|
|
ILLU
7617
Illumination Acquisition Corp I
ILLU
| $277 | ﹤0.01% |
+28
| New | +$277 |
2026 Q2
0 quarters
|
|
|
CAIE
7618
Calamos Autocallable Income ETF
CAIE
$1.31B
| $272 | ﹤0.01% |
10
| – | – |
2025 Q4
2 quarters
|
|
|
PMI
7619
Picard Medical
PMI
$22.2M
| $271 | ﹤0.01% |
33
-95
| -74% | -$2.02K |
2025 Q3
3 quarters
|
|
7620
AYTU BioPharma
AYTU
$22M
| $269 | ﹤0.01% |
125
| – | – |
2017 Q4
34 quarters
|
|
7621
SHF Holdings Warrants
SHFSW
| $269 | ﹤0.01% |
10,000
| – | – |
2022 Q3
15 quarters
|
|
7622
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$409M
| $268 | ﹤0.01% |
2
-1
| -33% | -$181 |
2014 Q1
49 quarters
|
|
7623
Direxion Daily Regional Banks Bull 3X ETF
DPST
$308M
| $267 | ﹤0.01% |
1
| – | – |
2020 Q4
22 quarters
|
|
|
MBVI
7624
M3-Brigade Acquisition VI Corp
MBVI
$442M
| $263 | ﹤0.01% |
26
-30
| -54% | -$303 |
2025 Q4
2 quarters
|
|
|
IPM
7625
Intelligent Protection Management Corp
IPM
$23.1M
| $261 | ﹤0.01% |
150
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.